Pharmacotherapeutic Management of Cardiovascular Disease Complications : a textbook for medical students.

Mostrar otras versiones (1)

Pharmacotherapeutic Management of Cardiovascular Disease Complications is an essential textbook which comprehensively informs the reader about a broad variety of cardiovascular pathologies and their management through drug therapy. Key Features:- Features 22 chapters, with 17 chapters dedicated to t...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Kumar, A. Bharath
Otros Autores: Umashankar, M. S.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Singapore : Bentham Science Publishers, [2020]
Temas:
Cardiovascular system > Diseases > Chemotherapy.
Appareil cardiovasculaire > Maladies > Chimiothérapie.
Cardiovascular system > Diseases > Chemotherapy
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Cover
  • Title
  • Copyright
  • End User License Agreement
  • Contents
  • Preface
  • CONSENT FOR PUBLICATION
  • CONFLICT OF INTEREST
  • ACKNOWLEDGEMENTS
  • Introduction to Heart Anatomy and Physiology
  • INTRODUCTION
  • Location of Heart
  • Size and Shape of the Heart
  • Chambers and Blood Circulation in the Heart
  • Heart Chambers
  • Blood Vessels
  • Heart valves
  • ANATOMY OF HEART
  • Left Side of the Heart
  • Right Side of the Heart
  • Covering Layers of Heart
  • The Internal Structural Pattern of the Heart
  • Right Atrium
  • Left Atrium
  • Right Ventricle
  • Left ventricle
  • PHYSIOLOGY OF THE HEART
  • Diastole
  • Conduction System of the Heart
  • Cardiac Cycle
  • Relaxation Phase
  • Blood Supply to Heart
  • Heart Sounds
  • Cardiac Output
  • CONCLUSION
  • REFERENCES
  • Role of Biomarkers in Detection of Cardiovascular Diseases
  • INTRODUCTION
  • IDEAL CHARACTERISTICS OF BIOMARKERS
  • MYOCARDIUM INJURY RISK PREDICTION BIOMARKERS
  • Cardiac Troponin
  • High-Sensitivity Cardiac Troponin (hs-cTn)
  • Heart-Type Fatty Acid Binding Protein (H-FABP)
  • INFLAMMATION PREDICTION BIOMARKERS
  • High-Sensitivity C-reactive Protein (hs-CRP)
  • Growth-Differentiation Factor-15 (GDF-15)
  • Fibrinogen
  • Uric Acid
  • PLAQUES RUPTURE ASSESSMENT BIOMARKERS
  • Myeloperoxidase (MPO)
  • Matrix Metalloproteinases
  • Pregnancy-Associated Plasma Protein-A (PAPP-A)
  • Platelet Activation Biomarkers
  • Secretory Phospholipase A2 (sPLA2)
  • Lipoprotein-Associated Phospholipase A2
  • Soluble CD40 Ligand (sCD40L)
  • BIOMARKERS OF NEUROHORMONAL ACTIVATION
  • Mid-Regional-Pro-Adrenomedullin
  • MYOCARDIAL DYSFUNCTION DETECTION BIOMARKERS ST
  • Endothelin-1 (ET-1)
  • Galectin-3
  • Neuregulin-1
  • BIOMARKERS OF MICRO RNAS (MIRNAS)
  • OTHER BIOMARKERS INVOLVED IN THE PREDICTION OF CARDIOVASCULAR DISEASE RISK PREDICTION
  • Neutrophil Gelatinase-Associated Lipocalin
  • Natriuretic Peptides
  • Apelin
  • Growth Differentiation Factor-15
  • Cyclophilin A
  • Prolactin
  • Heart-type Fatty Acid Binding Protein (H-FABP)
  • CONCLUSION
  • REFERENCES
  • Diagnostic Investigations for Detection of Cardiovascular Diseases
  • INTRODUCTION
  • CARDIOVASCULAR DISEASES: A GROUP OF DISORDERS OF THE HEART AND BLOOD VESSELS
  • Coronary Heart Disease
  • Cerebrovascular Disease
  • Peripheral Arterial Disease
  • Rheumatic Heart Disease
  • Congenital Heart Disease
  • Deep Vein Thrombosis and Pulmonary Embolism
  • RISK FACTORS FOR CARDIOVASCULAR DISEASE
  • DIAGNOSTIC INVESTIGATIONS FOR CARDIOVASCULAR DISEASES
  • Blood Analysis
  • Biomarkers for Detection of Cardiovascular Disease
  • B-type Natriuretic Peptides
  • Blood Urea Nitrogen
  • C-reactive Protein
  • Enzymes
  • Fibrinogen
  • Blood Sugar Test
  • Homocysteine
  • Lipid
  • OTHER CARDIOVASCULAR DISEASE DIAGNOSTIC INVEST-IGATIONS
  • CT Scan
  • Cardiac Catheterization
  • Echocardiography
  • Ejection Fraction Testing
  • Electrocardiogram
  • Electrophysiology Study

Ejemplares similares